Michael Thompson
Hematology & Oncology · Summit, WINPI 1265453070
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $73,938 of the $96,379 with a category attached, or 76.7%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 81.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $35,845 and has fallen 61.9% since, to $13,643 in 2022. Among hematology & oncology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $3011.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$79K
- AbbVie$4K
- Epizyme, Inc.$4K
- Sanofi$4K
- Adaptive Biotechnologies Corporation$3K
- Johnson & Johnson$2K
- plus $1K from 3 others
Across 89 payments — averaging $4334.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$77K
- Janssen Research & Development, LLC$76K
- Takeda Pharmaceuticals U.S.A., Inc.$70K
- AbbVie$67K
- GSK$38K
- Amgen$28K
- plus $30K from 4 others
What the payments were for
- Consulting fees$73,93877%
- Speaking & faculty fees$5,0505%
- Travel & lodging$16,70217%
- Food & beverage$6901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $78,820 |
| AbbVie | 1 | $4,200 |
| Epizyme, Inc. | 2 | $4,050 |
| Sanofi | 1 | $3,500 |
| Adaptive Biotechnologies Corporation | 1 | $2,900 |
| Johnson & Johnson | 1 | $1,768 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,000 |
| Osiris Therapeutics Inc. | 1 | $119 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$96,379 in reported general payments places this provider in the 95th percentile of 248 hematology & oncology providers in Wisconsin.
Other hematology & oncology in Summit
- Parameswaran HariMilwaukee$1.3M
- Sayed Mehdi HamadaniMilwaukee$546K
- Binod DhakalMilwaukee$535K
- Deepak KilariMilwaukee$359K
- Ehab AtallahMilwaukee$344K
- Nirav ShahMilwaukee$207K
- Razelle KurzrockMilwaukee$199K
- Syed AbutalibMilwaukee$154K
- Patrick FoyMilwaukee$132K
- Guru Subramanian Guru MurthyMilwaukee$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.